Research article
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
-
* Corresponding author: José M Navarro-Jarabo jnavarro@hcs.es
BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31
No comments have yet been made on this article.